Acollaboration between pharmacists and gastroenterologists to establish a standardized protocol for use of biologics in inflammatory bowel disease (IBD)—guided in part by telemedicine and data-mining electronic health records (EHRs)—has changed routine practice in a multicenter system and improved several quality-of-care benchmarks.
“A pharmacist-gastroenterologist co-management program for use of biologics in IBD patients is superior to a traditional